Literature DB >> 16977505

Is hepatitis C virus positivity a contributing factor to occult hepatitis B virus infection in hemodialysis patients?

Mehmet Kanbay1, Gurden Gur, Ali Akcay, Haldun Selcuk, Ugur Yilmaz, Hande Arslan, Sedat Boyacioglu, Fatma Nurhan Ozdemir.   

Abstract

Hepatitis B (HBV) infections continue to occur in adult hemodialysis units. Occult HBV infection (serum hepatitis B surface antigen [HBsAg] negative but HBV DNA positive) may be a contributing factor in these patients. This study was designed to (1) investigate the prevalence of occult HBV infection in hemodialysis patients and (2) compare the prevalence of occult HBV infection among hepatitis C (HCV)-positive and HCV-negative hemodialysis patients. The study included 138 patients on chronic hemodialysis. Eighty-four patients were HCV positive and 54 were HCV negative. HBV DNA testing was performed by polymerase chain reaction. We also recorded general characteristics of the patients, duration of hemodialysis, and serum alanine aminotransferase and aspartate aminotransferase levels. Twenty-one (15.2%) of the 138 hemodialysis patients were HBV DNA positive. Nine (16.6%) of the 54 anti-HCV antibody negative hemodialysis patients were HBV DNA positive. Twelve (14.2%) of the 84 anti-HCV antibody positive patients were HBV DNA positive. The prevalence in anti-HCV Ab positive and negative hemodialysis patients were same (P > .05). Hemodialysis duration, demographic features, and biochemical parameters were not significantly different in patients with and without occult HBV infection in both HCV-positive and -negative hemodialysis patients (P > .05). HCV positivity is not a contributing factor to occult HBV infection in hemodialysis patients. None of the parameters tested help to distinguish patients with occult HBV infection from those who are HBV DNA negative.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16977505     DOI: 10.1007/s10620-006-9421-9

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  14 in total

Review 1.  Persistent hepatitis B virus infection in subjects without hepatitis B surface antigen: clinically significant or purely "occult"?

Authors:  C Bréchot; V Thiers; D Kremsdorf; B Nalpas; S Pol; P Paterlini-Bréchot
Journal:  Hepatology       Date:  2001-07       Impact factor: 17.425

2.  Hepatitis B virus DNA is frequently found in liver biopsy samples from hepatitis C virus-infected chronic hepatitis patients.

Authors:  K Koike; M Kobayashi; M Gondo; I Hayashi; T Osuga; S Takada
Journal:  J Med Virol       Date:  1998-04       Impact factor: 2.327

Review 3.  Hepatitis B virus infection.

Authors:  W M Lee
Journal:  N Engl J Med       Date:  1997-12-11       Impact factor: 91.245

4.  Occult HBV infection and YMDD variants in hemodialysis patients with chronic HCV infection.

Authors:  Fatih Besisik; Cetin Karaca; Filiz Akyüz; Sibel Horosanli; Derya Onel; Selim Badur; Mehmet Sükrü Sever; Ahmet Danalioglu; Kadir Demir; Sabahattin Kaymakoglu; Yilmaz Cakaloglu; Atilla Okten
Journal:  J Hepatol       Date:  2003-04       Impact factor: 25.083

Review 5.  Epidemiology and prevention of hepatitis B.

Authors:  Miriam J Alter
Journal:  Semin Liver Dis       Date:  2003-02       Impact factor: 6.115

6.  Occult hepatitis B virus infection in a North American adult hemodialysis patient population.

Authors:  Gerald Y Minuk; Dong Feng Sun; Rebecca Greenberg; Manna Zhang; Kimberly Hawkins; Julia Uhanova; Adam Gutkin; Kevin Bernstein; Antonio Giulivi; Carla Osiowy
Journal:  Hepatology       Date:  2004-11       Impact factor: 17.425

7.  Hepatitis C and B viruses in hepatitis B surface antigen-negative hepatocellular carcinoma.

Authors:  J C Sheu; G T Huang; L N Shih; W C Lee; H C Chou; J T Wang; P H Lee; M Y Lai; C Y Wang; P M Yang
Journal:  Gastroenterology       Date:  1992-10       Impact factor: 22.682

8.  The risk of transmission of hepatitis B from HBsAg(-), HBcAb(+), HBIgM(-) organ donors.

Authors:  M E Wachs; W J Amend; N L Ascher; P N Bretan; J Emond; J R Lake; J S Melzer; J P Roberts; S J Tomlanovich; F Vincenti
Journal:  Transplantation       Date:  1995-01-27       Impact factor: 4.939

Review 9.  Occult hepatitis B virus infection and its clinical implications.

Authors:  Ke-Qin Hu
Journal:  J Viral Hepat       Date:  2002-07       Impact factor: 3.728

Review 10.  Occult hepatitis B.

Authors:  Michael Torbenson; David L Thomas
Journal:  Lancet Infect Dis       Date:  2002-08       Impact factor: 25.071

View more
  6 in total

Review 1.  Prevalence of occult hepatitis B virus infection.

Authors:  Maria Luisa Gutiérrez-García; Conrado M Fernandez-Rodriguez; Jose Luis Lledo-Navarro; Ingrid Buhigas-Garcia
Journal:  World J Gastroenterol       Date:  2011-03-28       Impact factor: 5.742

Review 2.  Current hepatitis B virus infection situation in Indonesia and its genetic diversity.

Authors:  Maria Inge Lusida; Yoshihiko Yano
Journal:  World J Gastroenterol       Date:  2016-08-28       Impact factor: 5.742

3.  Prevalence of occult hepatitis B virus infection in haemodialysis patients from central Greece.

Authors:  Paraskevi Mina; Sarah P Georgiadou; Christos Rizos; George N Dalekos; Eirini I Rigopoulou
Journal:  World J Gastroenterol       Date:  2010-01-14       Impact factor: 5.742

4.  Epidemiology of occult hepatitis B infection among thalassemic, hemophilia, and hemodialysis patients.

Authors:  Mohammad Kazemi Arababadi; Behzad Nasiri Ahmadabadi; Hassan Yousefi Daredor; Derek Kennedy
Journal:  Hepat Mon       Date:  2012-05-30       Impact factor: 0.660

5.  Post-transfusion occult hepatitis B (OBI): a global challenge for blood recipients and health authorities.

Authors:  Mohammad Kazemi Arababadi; Gholamhossein Hassanshahi; Ali Akbar Pourfathollah; Ebrahim Rezazadeh Zarandi; Derek Kennedy
Journal:  Hepat Mon       Date:  2011-09       Impact factor: 0.660

Review 6.  Viral hepatitis in hemodialysis: An update.

Authors:  Bassam Bernieh
Journal:  J Transl Int Med       Date:  2015-09-30
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.